To further evaluate the immune modulating effect of blocking IL-15 in IBD intestinal inflammation, we measured by ELISA the levels of IFN-γ and TNF-α secreted in the organ culture supernatants. The gene discussed is IL15; the disease is inflammatory bowel disease.